Navigation Links
UNC study reveals potential route to bladder cancer diagnostics, treatments
Date:2/11/2014

CHAPEL HILL, NC Researchers at the UNC School of Medicine conducted a comprehensive genetic analysis of invasive bladder cancer tumors to discover that the disease shares genetic similarities with two forms of breast cancer. The finding is significant because a greater understanding of the genetic basis of cancers, such as breast cancers, has in the recent past led to the development of new therapies and diagnostic aids.

Bladder cancer, which is the fourth most common malignancy in men and ninth in women in the United States, claimed more than 15,000 lives last year.

The analysis of 262 bladder cancer tumors, published online in the Proceedings of the National Academy of Sciences, revealed that the invasive form of the disease can be classified into two distinct genetic subtypes basal-like and luminal which were shown to be highly similar to the basal and luminal subtypes of breast cancer first described by Charles Perou, PhD, the May Goldman Shaw Distinguished Professor of Molecular Oncology at UNC Lineberger.

"It will be particularly interesting to see whether the bladder subtypes, like the breast subtypes, are useful in stratification for therapy," said lead author William Kim, MD, a researcher at the UNC Lineberger Comprehensive Cancer Center and associate professor in the departments of genetics and medicine at UNC.

Mapping genetic signaling pathways of breast cancer subtypes has led to the development of drugs to treat patients and diagnostic aids that help physicians determine the best course of therapy for patients. Because the identified bladder cancer subtypes share many of the same genetic signaling pathways of breast cancer, researchers hope that the identification of the genetic subtypes can lead to similar advances.

"Currently there are no approved targeted therapies for bladder cancer," said lead author Jeffrey Damrauer, graduate student in the Curriculum of Genetics and Molecular Biology at the UNC School of Medicine. "Our hope is that the identification of these subtypes will aid in the discovery of targetable pathways that will advance bladder cancer treatment."

The study also revealed a possible answer to why women diagnosed with bladder cancer have overall poorer outcomes compared to males. Analysis showed that female patients had a significantly higher incidence of the deadlier basal-like tumors. But researchers said that more research is needed before a definite link between the subtype and survival rate can be confirmed.

Dr. Kim's lab has developed a gene map BASE47 that proved successful as a prognostic aid when applied to the tumor samples in the study. The PAM50 genetic test, a similar genetic map developed in the Perou lab, was recently approved as a clinical diagnostic tool by the FDA.

Additional LCCC members contributing to this work are Katherine Hoadley, PhD; David Chism, MD; Cheng Fan; Christopher Tiganelli, MD; Sara Wobker, MD; Jen Jen Yeh, MD; Matthew Milowsky, MD; and Joel Parker, PhD.


'/>"/>

Contact: William Davis
william_davis@med.unc.edu
919-966-5906
University of North Carolina Health Care
Source:Eurekalert  

Related medicine news :

1. Study Suggests Vaccine May Help Kids With Brain Cancer
2. Study reveals how cancer drug causes diabetic-like state
3. Coffee Drinking in Pregnancy Wont Lead to Sleepless Baby: Study
4. Lower GI problems plague many with rheumatoid arthritis, Mayo Clinic study finds
5. Veggies Like Broccoli, Cabbage May Help Fight Breast Cancer: Study
6. No Added Cancer Risk From Hip Replacement Materials: Study
7. Reported Decline in U.S. Pneumonia Deaths May Be False: Study
8. Early Study Finds Some Promise for Lung Cancer Vaccine
9. Narcissists Often Ace Job Interviews, Study Finds
10. Sexual objectification of female artists in music videos exists regardless of race, MU study finds
11. Soy may alleviate hot flashes in menopause, large-scale study finds
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
UNC study reveals potential route to bladder cancer diagnostics, treatments
(Date:12/11/2016)... ... December 11, 2016 , ... Traditional cell phone chargers serve a very ... case for chargers used for tablets, portable laptops, and other mobile devices with rechargeable ... charges its respective device. An inventor from Floral Park, N.Y., has developed the patent-pending ...
(Date:12/11/2016)... ... , ... It’s hard for an inventor from Hanover, Pa., to spend time ... eyes and general discomfort associated with allergic reactions, he decided to develop an easy ... the patent-pending CLEAN AIR NOSE FILTER, an accessory that provides relief of allergic reactions ...
(Date:12/11/2016)... FL (PRWEB) , ... December 11, 2016 , ... ... to the online market. Skinerals Organic Skin Science has introduced 16 new products ... explains Michael Schindele, creator of Skinerals, "And we wanted to supply more products ...
(Date:12/11/2016)... , ... December 11, 2016 , ... ... has announced its 2017 program schedule, now available online. This year’s conference event ... research concerning eating disorders. The dynamic Symposium will take place March 22 - ...
(Date:12/10/2016)... ... December 09, 2016 , ... ... survival rates have increased greatly in recent years. This can be attributed to ... that progress hasn’t been equally distributed. In response, Mediaplanet’s latest, cross-platform edition of ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)...  Nevro Corp. (NYSE: NVRO ), a ... solutions for the treatment of chronic pain, today announced ... filed a lawsuit for patent infringement.  The lawsuit, filed ... of Delaware , alleges that Nevro ... stimulation leads, batteries, and telemetry units. ...
(Date:12/9/2016)... 2016 MSD, a nationally recognized supplier of ... alternate site health care facilities, announced today that it ... ("First Choice"), a privately held national distributor of medical ... home health segments. We would like to welcome First ... compelling transaction will deliver significant and immediate value to ...
(Date:12/9/2016)... , December 9, 2016 ... Subcutaneous ICD, Single-Chamber ICD, Dual-Chamber ICD, Cardiac Resynchronization ... Defibrillators, Wearable Cardioverter Defibrillators The ... at a CAGR of 5.3% from 2016-2020 and ... expected to grow at a CAGR of 5.2% ...
Breaking Medicine Technology: